Fresenius SE & Co. KGaA (FSNPF.PK), a health care company, on Wednesday reported higher earnings for the full year, supported by growth in revenue.
Group EBIT increased 4% to €2.595 billion from €2.489 billion a year ago, reflecting contributions from Fresenius Kabi's Growth Vectors and performance at Fresenius Helios in Spain.
Core net income grew 11% to €1.619 billion, or €2.87 per share from €1.461 billion or €2.59 per share last year.
Group revenue rose 5% to €22.554 billion from €21.526 billion. On an organic basis, revenue grew 7%.
The company plans to propose a dividend of €1.05 per share for fiscal 2025, 5% up year-on-year.
For fiscal 2026, Fresenius expects organic revenue growth of 4% to 7% and constant currency Core EPS growth of 5% to 10%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.